To establish an American Depositary Receipt program for its registered shares. Morgan Guaranty Trust Company will be the depository. Company characterizes the move as a "further step in broadening its international shareholder base". . . . Marion Merrell Dow's: Cardizem CD once-a-day diltiazem capsules for hypertension gains "approvable" status from FDA on Oct. 10; Cardizem Injectable approvable as of Oct. 4. MMD filed the NDA for Cardizem CD in February 1990 and for the NDA for I.V. diltiazem in October 1989. Plant inspections for the calcium channel blocker products are underway; labeling issues have been resolved for injectable Cardizem and negotiations are being completed for CD. . . .
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth